Validation of HyperDetector for SARS-CoV-2

Paused

Conditions studied: SARS-COV2 Infection

In brief

To evaluate the HyperDetector as a method to rapidly screen SARS-CoV-2 To determine the sensitivity and specificity of the screening assay performed on oral swab and saliva specimens, compared to a validated RT-PCR COVID-19 method using nasal or nasopharyngeal swabs and to separately collected nasal swabs, oral swabs, oral rinse and saliva samples. To determine the best workflow for using such an assay to reflex suspicious/positive samples to a validated RT-PCR COVID-19 assay.

Key facts

Study ID

NCT05124496

Run by

HyperSpectral APD

People needed

10000

Starts

2020-12-11

Expected to finish

2021-12-30

Last updated by the study team

2021-11-18

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects at COVID-19 testing site for Rt-PCR test.

You may not qualify if…

• Minors under the age of 5

Where it is running

• HyperSpectral APD, LLC — Alexandria, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.